WuXi Expands J&J Collaboration

WuXi PharmaTech (WX) announced that is has expanded its collaboration with Johnson & Johnson (JNJ). According to the release, WuXi will provide Janssen Pharmaceutica, a division of J&J Pharmaceutical Research & Development, with integrated research services in the area of discovery chemistry, discovery biology, chemical and analytical development services, formulation, and preclinical and bio-analytical services.

Previously, WuXi was supplying only discovery chemistry services to J&J.

WuXi did not disclose the terms for the new contract nor, for that matter, the previous one.

Disclosure: none.